Role of Defective Oct-2 and OCA-B Expression in Immunoglobulin Production and Kaposi's Sarcoma-Associated Herpesvirus Lytic Reactivation in Primary Effusion Lymphoma

ABSTRACT Primary effusion lymphoma (PEL) is a distinct type of B-cell non-Hodgkin lymphoma characterized by the presence of Kaposi's sarcoma-associated herpesvirus (KSHV/human herpesvirus 8). Despite having a genotype and gene expression signature of highly differentiated B cells, PEL does not usually express surface or cytoplasmic immunoglobulin (Ig). We show the lack of Oct-2 and OCA-B transcription factors to be responsible, at least in part, for this defect in Ig production. Like Ig genes, ORF50, the key regulator of the switch from latency to lytic reactivation, contains an octamer motif within its promoter. We therefore examined the impact of Oct-2 and OCA-B on ORF50 activation. The binding of Oct-1 to the ORF50 promoter has been shown to significantly enhance ORF50 transactivation. We found that Oct-2, on the other hand, inhibited ORF50 expression and consequently lytic reactivation by competing with Oct-1 for the octamer motif in the ORF50 promoter. Our data suggest that Oct-2 downregulation in infected cells would be favorable to KSHV in allowing for efficient viral reactivation.

[1]  J. Arapović,et al.  The NK Cell Response to Mouse Cytomegalovirus Infection Affects the Level and Kinetics of the Early CD8+ T-Cell Response , 2011, Journal of Virology.

[2]  Yan Wang,et al.  Essential role of RBP-Jkappa in activation of the K8 delayed-early promoter of Kaposi's sarcoma-associated herpesvirus by ORF50/RTA. , 2007, Virology.

[3]  Sanjay Tyagi,et al.  Kaposi's Sarcoma-Associated Herpesvirus Lytic Switch Protein Stimulates DNA Binding of RBP-Jk/CSL To Activate the Notch Pathway , 2006, Journal of Virology.

[4]  D. Aucoin,et al.  A Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8 ORF50 Deletion Mutant Is Defective for Reactivation of Latent Virus and DNA Replication , 2005, Journal of Virology.

[5]  H. Stein,et al.  Epigenetic silencing of the immunoglobulin heavy-chain gene in classical Hodgkin lymphoma-derived cell lines contributes to the loss of immunoglobulin expression. , 2004, Blood.

[6]  E. Cesarman,et al.  KSHV-Positive Solid Lymphomas Represent an Extra-Cavitary Variant of Primary Effusion Lymphoma , 2004, The American journal of surgical pathology.

[7]  L. Eckhardt,et al.  Critical Role for the Oct-2/OCA-B Partnership in Ig-Secreting Cells1 , 2003, The Journal of Immunology.

[8]  Frederick Y. Wu,et al.  CCAAT/Enhancer-Binding Protein- (cid:2) Is Induced during the Early Stages of Kaposi’s Sarcoma-Associated Herpesvirus (KSHV) Lytic Cycle Reactivation and Together with the KSHV Replication and Transcription Activator (RTA) Cooperatively Stimulates the Viral RTA, MTA, and PAN Promoters , 2003 .

[9]  Paul Kellam,et al.  Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[10]  R. Dalla‐Favera,et al.  Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts. , 2003, Blood.

[11]  Sonia Sharma,et al.  Disruption of the B-cell specific transcriptional program in HHV-8 associated primary effusion lymphoma cell lines , 2003, Oncogene.

[12]  Frederick Y. Wu,et al.  Role of CCAAT/Enhancer-Binding Protein Alpha (C/EBPα) in Activation of the Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Lytic-Cycle Replication-Associated Protein (RAP) Promoter in Cooperation with the KSHV Replication and Transcription Activator (RTA) and RAP , 2003, Journal of Virology.

[13]  Jiguo Chen,et al.  Octamer-Binding Sequence Is a Key Element for the Autoregulation of Kaposi's Sarcoma-Associated Herpesvirus ORF50/Lyta Gene Expression , 2001, Journal of Virology.

[14]  G. Lenz,et al.  Defective octamer-dependent transcription is responsible for silenced immunoglobulin transcription in Reed-Sternberg cells. , 2001, Blood.

[15]  V. Diehl,et al.  Oct-2 and Bob-1 deficiency in Hodgkin and Reed Sternberg cells. , 2001, Cancer research.

[16]  R. Sun,et al.  Auto-activation of the rta gene of human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus. , 2000, The Journal of general virology.

[17]  E. Cesarman,et al.  Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells. , 2000, Blood.

[18]  Sarah Nikiforow,et al.  Kaposi's Sarcoma-Associated Herpesvirus Open Reading Frame 50/Rta Protein Activates the Entire Viral Lytic Cycle in the HH-B2 Primary Effusion Lymphoma Cell Line , 2000, Journal of Virology.

[19]  R. Roeder,et al.  Role of OCA-B in 3′-IgH Enhancer Function1 , 2000, The Journal of Immunology.

[20]  A. Polack,et al.  Inducible loss of NF-kappaB activity is associated with apoptosis and Bcl-2 down-regulation in Epstein-Barr virus-transformed B lymphocytes. , 2000, Blood.

[21]  D. Ganem,et al.  Transcriptional Activation by the Product of Open Reading Frame 50 of Kaposi’s Sarcoma-Associated Herpesvirus Is Required for Lytic Viral Reactivation in B Cells , 1999, Journal of Virology.

[22]  G. Gaidano,et al.  Immunoglobulin V region gene use and structure suggest antigen selection in AIDS-related primary effusion lymphomas , 1999, Leukemia.

[23]  G. Gaidano,et al.  Genetic characterization of HHV‐8/KSHV–positive primary effusion lymphoma reveals frequent mutations of BCL6: Implications for disease pathogenesis and histogenesis , 1999, Genes, chromosomes & cancer.

[24]  D. Ganem,et al.  Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein. , 1998, Virology.

[25]  E. Cesarman,et al.  Immunoglobulin VH gene mutational analysis suggests that primary effusion lymphomas derive from different stages of B cell maturation. , 1998, The American journal of pathology.

[26]  R. Sun,et al.  A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[27]  W. Herr,et al.  OCA-B Is a Functional Analog of VP16 but Targets a Separate Surface of the Oct-1 POU Domain , 1998, Molecular and Cellular Biology.

[28]  G. Gaidano,et al.  Association of Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma with expression of the CD138/syndecan-1 antigen. , 1997, Blood.

[29]  D. Karcher,et al.  Human herpesvirus-8-associated body cavity-based lymphoma in human immunodeficiency virus-infected patients: a unique B-cell neoplasm. , 1997, Human pathology.

[30]  R. Sun,et al.  Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells , 1997, Journal of virology.

[31]  G. Gaidano,et al.  Kaposi's sarcoma‐associated herpesvirus DNA sequences in AIDS‐related and AIDS‐unrelated lymphomatous effusions , 1996, British journal of haematology.

[32]  E. Cesarman,et al.  Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. , 1996, Blood.

[33]  L. Picker,et al.  Primary body cavity-based AIDS-related lymphomas. , 1996, American journal of clinical pathology.

[34]  F. Sigaux,et al.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. , 1995, Blood.

[35]  R. Roeder,et al.  Cloning, functional characterization, and mechanism of action of the B-cell-specific transcriptional coactivator OCA-B , 1995, Molecular and cellular biology.

[36]  E. Cesarman,et al.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. , 1995, The New England journal of medicine.

[37]  J. Newell,et al.  OBF-1, a novel B cell-specific coactivator that stimulates immunoglobulin promoter activity through association with octamer-binding proteins , 1995, Cell.

[38]  C. Hovens,et al.  A B-cell coactivator of octamer-binding transcription factors , 1995, Nature.

[39]  E. Cesarman,et al.  Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. , 1994, Science.

[40]  L. Madisen,et al.  Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells. , 1994, Genes & development.

[41]  D. Baltimore,et al.  The immunoglobulin heavy chain locus contains another B-cell-specific 3' enhancer close to the alpha constant region , 1993, Molecular and cellular biology.

[42]  R. Hipskind,et al.  Analysis of transcriptional stimulation by recombinant Oct proteins in a cell-free system. , 1993, The Journal of biological chemistry.

[43]  A. Morley,et al.  Improved PCR method for detecting monoclonal immunoglobulin heavy chain rearrangement in B cell neoplasms. , 1992, Journal of clinical pathology.

[44]  D. Latchman,et al.  The octamer-binding protein Oct-2 represses HSV immediate-early genes in cell lines derived from latently infectable sensory neurons , 1991, Neuron.

[45]  T. Jenuwein,et al.  Complex pattern of immunoglobulin mu gene expression in normal and transgenic mice: nonoverlapping regulatory sequences govern distinct tissue specificities. , 1991, Genes & development.

[46]  M. Neuberger,et al.  The mouse IgH 3′‐enhancer , 1991, European journal of immunology.

[47]  L. Eckhardt,et al.  An enhancer at the 3' end of the mouse immunoglobulin heavy chain locus. , 1991, Nucleic acids research.

[48]  A. Morley,et al.  Monoclonality in B cell lymphoma detected in paraffin wax embedded sections using the polymerase chain reaction. , 1990, Journal of clinical pathology.

[49]  J. Said,et al.  Diagnosis of malignant lymphoma in effusions from patients with AIDS by gene rearrangement. , 1990, American journal of clinical pathology.

[50]  M. Neuberger,et al.  A second B cell-specific enhancer 3' of the immunoglobulin heavy-chain locus , 1990, Nature.

[51]  W. Herr,et al.  Differential transcriptional activation by Oct-1 and Oct-2: Interdependent activation domains induce Oct-2 phosphorylation , 1990, Cell.

[52]  G. Inghirami,et al.  Molecular genetic analysis of three AIDS-associated neoplasms of uncertain lineage demonstrates their B-cell derivation and the possible pathogenetic role of the Epstein-Barr virus. , 1989, Blood.

[53]  W. Schaffner,et al.  A cloned octamer transcription factor stimulates transcription from lymphoid–specific promoters in non–B cells , 1988, Nature.

[54]  R. Roeder,et al.  A human lymphoid- specific transcription factor that activates immunoglobulin genes is a homoeobox protein , 1988, Nature.

[55]  P. Sharp,et al.  The B-cell-specific Oct-2 protein contains POU box- and homeo box-type domains. , 1988, Genes & development.

[56]  P. O’Hare,et al.  Direct combinatorial interaction between a herpes simplex virus regulatory protein and a cellular octamer‐binding factor mediates specific induction of virus immediate‐early gene expression. , 1988, The EMBO journal.

[57]  W. Herr,et al.  The ubiquitous octamer-binding protein Oct-1 contains a POU domain with a homeo box subdomain. , 1988, Genes & development.

[58]  M. Frame,et al.  A complex formed between cell components and an HSV structural polypeptide binds to a viral immediate early gene regulatory DNA sequence , 1988, Cell.

[59]  L. Staudt,et al.  An octamer oligonucleotide upstream of a TATA motif is sufficient for lymphoid-specific promoter activity , 1987, Nature.

[60]  M. Dreyfus,et al.  The conserved decanucleotide from the immunoglobulin heavy chain promoter induces a very high transcriptional activity in B‐cells when introduced into an heterologous promoter. , 1987, The EMBO journal.

[61]  W. Schaffner,et al.  Cell type‐specificity elements of the immunoglobulin heavy chain gene enhancer. , 1987, The EMBO journal.

[62]  J. Mizushima-Sugano,et al.  Cell-type-specific transcription of an immunoglobulin kappa light chain gene in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[63]  P. Pellett,et al.  Nucleotide sequence and predicted amino acid sequence of a protein encoded in a small herpes simplex virus DNA fragment capable of trans-inducing alpha genes. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[64]  M. Neuberger,et al.  Transcription cell type specificity is conferred by an immunoglobulin VH gene promoter that includes a functional consensus sequence , 1985, Cell.

[65]  J. Palfreyman,et al.  Identification of herpes simplex virus DNA sequences which encode a trans-acting polypeptide responsible for stimulation of immediate early transcription. , 1984, Journal of molecular biology.

[66]  D. Baltimore,et al.  Two regulatory elements for immunoglobulin kappa light chain gene expression. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[67]  W. Murphy,et al.  Structure of the 5' ends of immunoglobulin genes: a novel conserved sequence. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[68]  H. Zachau,et al.  Correct transcription of an immunoglobulin κ gene requires an upstream fragment containing conserved sequence elements , 1984, Nature.

[69]  S. Tonegawa,et al.  A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene , 1983, Cell.

[70]  J. Banerji,et al.  A lymphocyte-specific cellular enhancer is located downstream of the joining region in immunoglobulin heavy chain genes , 1983, Cell.

[71]  B. Roizman,et al.  Characterization of the herpes simplex virion-associated factor responsible for the induction of alpha genes , 1983, Journal of virology.

[72]  S. Mackem,et al.  Regulation of α genes of herpes simplex virus: Expression of chimeric genes produced by fusion of thymidine kinase with α gene promoters , 1981, Cell.

[73]  S. Rivest,et al.  Cloning of murine TReP-132, a novel transcription factor expressed in brain regions involved in behavioral and psychiatric disorders , 2003, Molecular Psychiatry.

[74]  M. Sigvardsson,et al.  Transcriptional regulation in B cell differentiation. , 1999, Critical reviews in immunology.

[75]  K. Calame,et al.  Transcriptional regulation during B cell development. , 1998, Annual review of immunology.

[76]  M. Ladanyi,et al.  Primary lymphomatous effusions in AIDS: a morphological, immunophenotypic, and molecular study. , 1995, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[77]  Harinder Singh,et al.  Genetic analysis of transcription factors implicated in B lymphocyte development , 1994, Immunologic research.

[78]  W. Herr,et al.  Differential positive control by Oct-1 and Oct-2: activation of a transcriptionally silent motif through Oct-1 and VP16 corecruitment. , 1993, Genes & development.

[79]  S. Mackem,et al.  Regulation of alpha genes of herpes simplex virus: expression of chimeric genes produced by fusion of thymidine kinase with alpha gene promoters. , 1981, Cell.